E-mail this story
Why the delay in release of FDA documents on gene-modified salmon?
The Food and Drug Administration released long-awaited documents Dec. 21 on genetically modified salmon: an assessment of the fish’s potential environmental effects and a preliminary “finding of no significant impact” of the fish on the environment. This brings AquAdvantage salmon -- Atlantic salmon that has been modified with a growth hormone gene from chinook salmon so that it reaches maturity faster -- a significant step closer to FDA approval.
By Rosie Mestel
December 26, 2012